(Q36972772)

17 August 2017

1 reference

title

Is ganglioside GM1 effective in the treatment of stroke? (English)

1 reference

17 August 2017

Is Ganglioside GM1 Effective in the Treatment of Stroke? (English)

1 reference

10.2165/00002512-199101010-00007

Crossref

DOI

https://api.crossref.org/works/10.2165/00002512-199101010-00007

27 November 2022

author name string

S. Braune

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794005

27 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1794005

27 November 2022

publication date

1 January 1991

1 reference

17 August 2017

1 reference

17 August 2017

volume

1

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

57-66

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199101010-00007

17 August 2017

exact match

0 references

cites work

Assessment of interobserver variability in a Dutch multicenter study on acute ischemic stroke

1 reference

12 December 2020

GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug

1 reference

12 December 2020

Time dependent effect of GM, ganglioside administration upon [(3)H]5-hydroxytryptamine uptake in partially denervated rat hippocampus

1 reference

12 December 2020

Glutamate and the pathophysiology of hypoxic--ischemic brain damage

1 reference

12 December 2020

Ganglioside-induced neuritogenesis: verification that gangliosides are the active agents, and comparison of molecular species.

1 reference

12 December 2020

Pharmacological treatment of central nervous system injury

1 reference

12 December 2020

Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke

1 reference

12 December 2020

Observer variability in assessing the clinical features of subarachnoid hemorrhage

1 reference

12 December 2020

Neural plasticity of basal forebrain cholinergic neurons: effects of gangliosides

1 reference

12 December 2020

Ganglioside GM1 does not initiate, but enhances neurite regeneration of nerve growth factor-dependent sensory neurones

1 reference

12 December 2020

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

1 reference

12 December 2020

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

12 December 2020

Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons

1 reference

12 December 2020

The decline of stroke

1 reference

12 December 2020

GM1 ganglioside accelerates neurite outgrowth from primary peripheral and central neurons under selected culture conditions.

1 reference

12 December 2020

The effect of GM1 ganglioside on coerulospinal, noradrenergic, adult neurons and on fetal monoaminergic neurons transplanted into the transected spinal cord of the adult rat.

1 reference

12 December 2020

Gangliosides minimize behavioral deficits and enhance structural repair after brain injury.

1 reference

12 December 2020

Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: serum- and NGF-dependent effects on neuritic growth (and proliferation)

1 reference

12 December 2020

Trial of ganglioside GM1 in acute stroke

1 reference

12 December 2020

The effect of GM1 ganglioside on cholinergic and serotoninergic systems in the rat hippocampus following partial denervation is dependent on the degree of fiber degeneration.

1 reference

12 December 2020

The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke

1 reference

12 December 2020

Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation

1 reference

12 December 2020

The Hamburg Stroke Data Bank: goals, design and preliminary results

1 reference

12 December 2020

Calcium/ganglioside-dependent protein kinase activity in rat brain membrane.

1 reference

12 December 2020

Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor

1 reference

12 December 2020

Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. I: Goals, objectives, and data collection procedures

1 reference

12 December 2020

Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor.

1 reference

12 December 2020

Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex

1 reference

12 December 2020

Brain plasticity as a basis of the development of rehabilitation procedures for hemiplegia.

1 reference

12 December 2020

Comparison of spontaneously recovered versus nonrecovered patients with poststroke depression

1 reference

12 December 2020

Effect of the ganglioside GM1, on cerebral metabolism, microcirculation, recovery kinetics of ECoG and histology, during the recovery period following focal ischemia in cats

1 reference

12 December 2020

The facilitating effect of gangliosides on the electrogenic (Na+/K+) pump and on the resistance of the membrane potential to hypoxia in neuromuscular preparation.

1 reference

12 December 2020

Interobserver variability in the assessment of neurologic history and examination in the Stroke Data Bank

1 reference

12 December 2020

Prognosis of acute stroke

1 reference

12 December 2020

Gangliosides modulate glutamate receptor binding in rat brain synaptic plasma membranes.

1 reference

12 December 2020

Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides.

1 reference

12 December 2020

Ganglioside GM1 overcomes serum inhibition of neuritic outgrowth

1 reference

12 December 2020

Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1.

1 reference

12 December 2020

Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat

1 reference

12 December 2020

Parenterally administered GM1 ganglioside prevents retrograde degeneration of cholinergic cells of the rat basal forebrain

1 reference

12 December 2020

Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting

1 reference

12 December 2020

Prospective investigations: the Framingham study and the epidemiology of stroke

1 reference

12 December 2020

GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system

1 reference

12 December 2020

Striatal and cortical acetylcholine release in vivo in rats with unilateral decortication: effects of treatment with monosialoganglioside GM1

1 reference

12 December 2020

GM1 gangliosides stimulate neuronal reorganization and reduce rotational asymmetry after hemitransections of the nigro-striatal pathway.

1 reference

12 December 2020

FUNCTIONAL EVALUATION: THE BARTHEL INDEX

1 reference

12 December 2020

Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse

1 reference

12 December 2020

Gangliosides enhance neurite outgrowth in PC12 cells

1 reference

12 December 2020

Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.

1 reference

12 December 2020

Central nervous system lesions: sprouting and unmasking in rehabilitation

1 reference

12 December 2020

Recovery of motor function after stroke

1 reference

12 December 2020

Effect of the ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion in cats

1 reference

12 December 2020

Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain.

1 reference

12 December 2020

Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins

1 reference

12 December 2020

Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases

1 reference

12 December 2020

Assessment of inter-observer differences in the Italian multicenter study on reversible cerebral ischemia

1 reference

12 December 2020

A quantitative investigation of the development of collateral reinnervation after partial deafferentation of the septal nuclei.

1 reference

12 December 2020

Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside

1 reference

12 December 2020

Retrograde changes in the nucleus basalis of the rat, caused by cortical damage, are prevented by exogenous ganglioside GM1.

1 reference

12 December 2020

Acute effects of GM1 ganglioside: reduction in both behavioral asymmetry and loss of Na+, K+-ATPase after nigrostriatal transection

1 reference

12 December 2020

The Canadian Neurological Scale: a preliminary study in acute stroke

1 reference

12 December 2020

Rehabilitation outcome following initial unilateral hemispheric stroke. Life table analysis approach

1 reference

12 December 2020

Antiganglioside antibodies inhibit neuritic outgrowth from regenerating goldfish retinal explants.

1 reference

12 December 2020

Reduction of cerebral edema with GM1 ganglioside

1 reference

12 December 2020

Antibodies to gangliosides inhibit goldfish optic nerve regeneration in vivo

1 reference

12 December 2020

Predicting the outcome of acute stroke: a prognostic score

1 reference

12 December 2020

Prediction of function after stroke: a critical review

1 reference

12 December 2020

United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group

1 reference

12 December 2020

CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*

1 reference

12 December 2020

Neuritogenic and metabolic effects of individual gangliosides and their interaction with nerve growth factor in cultures of neuroblastoma and pheochromocytoma

1 reference

12 December 2020

Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function

1 reference

12 December 2020

Morphological and Biochemical Effects of Gangliosides in Neuroblastoma Cells

1 reference

12 December 2020

10.2165/00002512-199101010-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

1036137947

0 references

1 reference